L. Becker Hewes - Oct 15, 2021 Form 4 Insider Report for Blueprint Medicines Corp (BPMC)

Role
Chief Medical Officer
Signature
/s/ Ariel Hurley, Attorney-in-Fact
Stock symbol
BPMC
Transactions as of
Oct 15, 2021
Transactions value $
-$26,550
Form type
4
Date filed
10/19/2021, 04:04 PM
Previous filing
Sep 17, 2021
Next filing
Nov 17, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BPMC Common Stock Options Exercise $48.3K +729 +2.78% $66.24 26.9K Oct 15, 2021 Direct F1
transaction BPMC Common Stock Sale -$74.8K -729 -2.71% $102.66 26.2K Oct 15, 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BPMC Stock Option (Right to Buy) Options Exercise $0 -729 -2.78% $0.00 25.5K Oct 15, 2021 Common Stock 729 $66.24 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Effected pursuant to a trading plan adopted on August 13, 2021 pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.
F2 This option was granted on June 1, 2020. This option vested with respect to 25% of the shares underlying the option on June 1, 2021 and as to an additional 1/48th of the shares underlying the option each month thereafter.